Urinary brain-derived neurotrophic factor: A potential biomarker for objective diagnosis of overactive bladder

International Urology and Nephrology

Volumn 46, Issue 2, 2014, Pages 341-347

  Wang, Long Wang ^a   Han, Xiao Min ^b   Chen, Chao Hui ^b   Ma, Yan ^b   Hai, Bo ^b  

^a NANCHANG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Biomarker; Brain derived neurotrophic factor; Nerve growth factor; Overactive bladder; Urinary continence

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CREATININE; NERVE GROWTH FACTOR;

ADULT; ARTICLE; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERACTIVE BLADDER; OVERACTIVE BLADDER SYMPTOM SCORE; PROTEIN URINE LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; NERVE GROWTH FACTOR; ROC CURVE; SEVERITY OF ILLNESS INDEX; URINARY BLADDER, OVERACTIVE;

EID: 84896702787     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0540-x     Document Type: Article

References (32)

1. Milsom I, Kaplan SA, Coyne KS et al (2012) Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology 80:90
2. Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327
3. Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167
4. NIDDK (2013) Urodynamic testing. National institute of diabetes and digestive and kidney diseases. http://kidney.niddk.nih.gov/kudiseases/pubs/bcw- ez. Accessed 16 May
5. Rovner ES, Goudelocke CM (2010) Urodynamics in the evaluation of overactive bladder. Curr Urol Rep 11:343
6. Steers WD, Tuttle JB (2006) Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 3:101
7. Ochodnicky P, Cruz CD, Yoshimura N et al (2011) Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target. Neurourol Urodyn 30:1227
8. Kuo HC, Liu HT, Chancellor MB (2010) Can urinary nerve growth factor be a biomarker for overactive bladder? Rev Urol 12:e69
9. Liu HT, Kuo HC (2008) Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 179:2270
10. Antunes-Lopes T, Carvalho-Barros S, Cruz CD et al (2011) Biomarkers in overactive bladder: a new objective and noninvasive tool? Adv Urol 2011, Article ID 382431
11. Antunes-Lopes T, Pinto R, Carvalho-Barros S et al (2011) Urinary levels of brain-derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur Urol Suppl 10:277
12. Kuo HC, Liu HT, Chancellor MB (2010) Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol Urodyn 29:482
13. Kim JC, Park EY, Seo SI et al (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175: 1773; discussion 1776
14. Kim JC, Park EY, Hong SH et al (2005) Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int J Urol 12:875
15. Liu HT, Tyagi P, Chancellor MB et al (2010) Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int 106:1681
16. Ghoniem G, Faruqui N, Elmissary M et al (2011) Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J 22:953
17. Bhide AA, Cartwright R, Khullar V et al (2013) Biomarkers in overactive bladder. Int Urogynecol J 12 Jan (Epub ahead of print.)
18. Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome-overactive bladder symptom score. Urology 68:318
19. Liu HT, Tyagi P, Chancellor MB et al (2009) Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 104:1476
20. Florkowski CM (2008) Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. Lin Biochem Rev 29(Suppl 1):S83
21. Mandrekar JN (2010) Receiver operating characteristics curve in diagnostic test assessment. J Thorac Oncol 5:1315
22. Liu HT, Kuo HC (2008) Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Urology 72: 104; discussion 108
23. Liu HT, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56:700
24. Obata K, Noguchi K (2006) BDNF in sensory neurons and chronic pain. Neurosci Res 55:1
25. Oddiah D, Anand P, McMahon SB et al (1998) Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. NeuroReport 9:1455
26. Di Luca M, Gardoni F, Finardi A et al (2001) NMDA receptor subunits are phosphorylated by activation of neurotrophin receptors in PSD of rat spinal cord. NeuroReport 12:1301
27. Cruz Duarte P, St-Jacques B, Ma W (2012) Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neurons in ganglion explant cultures and in a neuropathic pain model. Exp Neurol 234:466
28. Pezet S, McMahon SB (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507
29. Qiao LY, Vizzard MA (2002) Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways. J Comp Neurol 454:200
30. Qiao LY, Vizzard MA (2005) Spinal cord injury-induced expression of TrkA, TrkB, phosphorylated CREB, and c-Jun in rat lumbosacral dorsal root ganglia. J Comp Neurol 482:142
31. Pinto R, Frias B, Allen S, Dawbarn D et al (2010) Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience 166:907
32. Pinto R, Lopes T, Frias B et al (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol 58:360